Search results for "rex"

showing 10 items of 701 documents

The Objective and Subjective Caregiving Burden and Caregiving Behaviours of Parents of Adolescents with Anorexia Nervosa

2015

Objective: The study aimed to examine caregiving burden and levels of distress, accommodating behaviours, expressed emotion (EE) and carers' skills, in parents of adolescents with anorexia nervosa. Method: A semi-structured interview assessed the objective burden (time spent across caregiving tasks) in parents (n = 196) of adolescents (n = 144) receiving outpatient treatment for anorexia nervosa. Subjective burden (carers' distress), accommodating behaviours, EE and carers' skills were measured by self-report. Results: Mothers, on average, spent 2.5 h/day of care, mainly providing food and emotional support, compared with 1 h/day by fathers. The level of distress and accommodating behaviour…

AdultMaleParentsParenting/psychologyAdolescentAnorexia Nervosa/psychologycaregiving burdenMothersStressbehavioral disciplines and activitiesanorexia nervosaPsychological/psychologyCaregivers/psychologySurveys and Questionnairesmental disordersAmbulatory CareHumansParent-Child RelationsMaternal BehaviorPaternal Behavioraccommodating and enabling behaviourParentingDepressionMiddle AgedExpressed EmotionClinical PsychologyCaregiversPsychiatry and Mental Healthexpressed emotionFemalecarer skillDepression/psychologyStress PsychologicalParents/psychology
researchProduct

Molecular characterisation and expression analysis of SEREX-defined antigen NUCB2 in gastric epithelium, gastritis and gastric cancer.

2009

NUCB2 is an EF-hand Ca2+ binding protein that has been implicated in various physiological processes like calcium homeostasis, hypothalamic regulation of feeding and TNF receptor shedding. In our previous study we identified NUCB2 as a potential tumour antigen eliciting autoantibody responses in 5.4% of gastric cancer patients but not in the healthy individuals.The current study aimed to elucidate the molecular mechanism underlying NUCB2 immunogenicity and to gain an insight into the physiological functions of NUCB2 in the stomach. mRNA expression analysis demonstrated that NUCB2 is ubiquitously expressed in normal tissues, including lymphoid tissues, and downregulated in gastric tumours wh…

AdultMalePathologymedicine.medical_specialtyHistologyNUCB2BiophysicsDown-RegulationNerve Tissue ProteinsBiologyAntigenWestern blotchief cellsParietal Cells GastricStomach NeoplasmsGastric glandsGastric mucosamedicineHumansNucleobindinsEnterochromaffin-like celllcsh:QH301-705.5AgedAutoantibodiesAged 80 and overOriginal Papermedicine.diagnostic_testReverse Transcriptase Polymerase Chain ReactionStomachgastric cancerCalcium-Binding Proteinsparietal cellsCell BiologySEREXMiddle AgedMolecular biologyGastric chief cellDNA-Binding Proteinsmedicine.anatomical_structurelcsh:Biology (General)Gastric MucosaGastritisCancer cellpepsinogen secretion.Femaletumour-associated antigensProtein Processing Post-TranslationalEuropean journal of histochemistry : EJH
researchProduct

The association between smoking prevalence and eating disorders: a systematic review and meta-analysis

2016

BACKGROUND AND AIMS: Cigarette smoking is associated with severe mental illness, including schizophrenia and bipolar disorder, and with morbidity and mortality, but the association with anorexia (AN), bulimia nervosa (BN) and binge eating disorder (BED) is unclear. This meta-analysis compared the odds of smoking in eating disorders (ED) (ED = AN or BN or BED) versus healthy controls (HC) and calculated the prevalence of smokers in people with ED. METHODS: Three independent authors searched PubMed, MEDLINE and Scopus from database inception until 31 December 2015 for studies reporting data on life-time or current smoking prevalence in BED, BN and AN with or without control group. Meta-analys…

AdultMaleSex Factormeta-analysiRegression AnalysiCigarette SmokingFeeding and Eating DisordersYoung AdultSex FactorsBinge eating disordermental disordersPrevalenceAnorexia nervosa binge eating disorder bulimia nervosa eating disorders meta-analysis moderators smoking.Feeding and Eating DisorderHumansAnorexia nervosa; Binge eating disorder; Bulimia nervosa; Eating disorders; Meta-analysis; Moderators; SmokingSmokingModeratorsmoderatorAnorexia nervosaHealthy VolunteerHealthy VolunteersMeta-analysisBulimia nervosaeating disorderEating disordersRegression AnalysisFemaleHuman
researchProduct

Temporary stages and motivational variables: Two complementary perspectives in the help-seeking process for mental disorders

2018

Abstract Introduction Help-seeking for mental disorders is a complex process, which includes different temporary stages, and in which the motivational variables play an especially relevant role. However, there is a lack of instruments to evaluate in depth both the temporary and motivational variables involved in the help-seeking process. This study aims to analyse in detail these two sets of variables, using a specific instrument designed for the purpose, to gain a better understanding of the process of treatment seeking. Material and methods A total of 152 patients seeking treatment in mental health outpatient clinics of the NHS were individually interviewed: 71 had Obsessive-Compulsive Di…

AdultMaleTime FactorsAnorexia nervosaInterviews as Topic03 medical and health sciences0302 clinical medicineQuality of life (healthcare)medicineHumansOutpatient clinicAgedRetrospective StudiesMotivationMental DisordersGeneral MedicineMiddle AgedPatient Acceptance of Health Caremedicine.diseaseMental health030227 psychiatryCross-Sectional StudiesMoodStructured interviewMajor depressive disorderFemalePsychology030217 neurology & neurosurgeryAgoraphobiaClinical psychologyRevista de Psiquiatría y Salud Mental (English Edition)
researchProduct

Tumour necrosis factor (TNF) production by T cell receptor-primed T lymphocytes is a target for low dose methotrexate in rheumatoid arthritis

1999

SUMMARYMethotrexate (MTX) is an effective immunosuppressive agent in various chronic inflammatory diseases such as rheumatoid arthritis (RA). However, its mechanisms of action are only partially understood. In this study, we assessed the effects of MTX on the differentiation of peripheral blood (PB) CD4+CD45RA ‘naive’ and CD4+CD45RO ‘memory’ T cells from healthy controls and patients with RA. Accordingly, purified T cells were primed and restimulated in vitro via the T cell receptor (TCR) in the presence of IL-2 to generate effector T cells secreting large amounts of Th1 and Th2 cytokines. We observed that low doses of MTX strongly suppress TNF and to a lesser extent interferon-gamma (IFN-γ…

AdultMaleTime FactorsT-LymphocytesT cellImmunologyReceptors Antigen T-CellPriming (immunology)Enzyme-Linked Immunosorbent AssayMonocytesArthritis RheumatoidInterferon-gammaAntigens CDimmune system diseasesmedicineHumansImmunology and AllergyCytotoxic T cellCells CulturedB-LymphocytesDose-Response Relationship DrugTumor Necrosis Factor-alphabusiness.industryMonocyteSynovial MembraneT-cell receptorCell DifferentiationOriginal ArticlesT lymphocyteMiddle Agedmedicine.diseaseMethotrexatemedicine.anatomical_structureAntirheumatic AgentsRheumatoid arthritisImmunologyCytokinesFemaleTumor necrosis factor alphabusinessClinical and Experimental Immunology
researchProduct

Time course of adverse events most commonly associated with topiramate for migraine prevention

2007

The efficacy, safety and tolerability of topiramate has been demonstrated in three large multicenter, randomized, double-blind, placebo-controlled trials. To characterize the time course of adverse events (AEs) that led to treatment discontinuation in/=2% of patients who received topiramate 100 mg/day during three pivotal, multicenter, randomized, double-blind, placebo-controlled, and 26-week trials. The pooled population comprised all randomized patients who reported safety data during the double-blind phase (topiramate 100 mg/day, n = 386; placebo n = 372), which consisted of a 4-week titration period and a 22-week maintenance period. Incidence, time to onset, and cumulative mean rate of …

AdultMaleTopiramateTime FactorsNauseaMigraine DisordersPopulationFructosePlaceboTimelaw.inventionPlacebosDouble-Blind MethodRandomized controlled trialTopiramatelawmedicineHumansParesthesiaeducationFatigueeducation.field_of_studyDose-Response Relationship Drugbusiness.industryNauseaMiddle Agedmedicine.diseaseAnorexiaDiscontinuationWithholding TreatmentNeurologyTolerabilityMigraineAnesthesiaPatient ComplianceAnticonvulsantsFemaleNeurology (clinical)medicine.symptomCognition Disordersbusinessmedicine.drugEuropean Journal of Neurology
researchProduct

Therapeutic Drug Monitoring of Naltrexone and 6β-Naltrexol During Anti-craving Treatment in Alcohol Dependence: Reference Ranges.

2018

Aims Aim of this study was to associate concentration of naltrexone and its major active metabolite 6β-naltrexol in blood with therapeutic outcome during treatment with naltrexone in subjects with alcohol dependence. Treatment with the μ-opiate receptor antagonist naltrexone has been shown to reduce craving for alcohol and alcohol intake in patients suffering from alcohol dependence. Short summary This article shows the use of therapeutic drug monitoring in alcohol dependent patients, who are treated with naltrexone. The plasma concentrations of naltrexone and 6β-naltrexol showed high inter-individual variability. They were predictive for treatment response, as they correlated significantly…

AdultMalemedicine.drug_classAcamprosateNarcotic Antagonists030508 substance abuseCravingAlcoholPharmacologyNaltrexone03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDouble-Blind MethodReference ValuesmedicineHumansActive metaboliteCravingEthanolmedicine.diagnostic_testbusiness.industryAlcohol dependenceGeneral MedicineMiddle AgedReceptor antagonistNaltrexoneAlcoholismTreatment OutcomechemistryTherapeutic drug monitoringDrug Therapy CombinationFemalemedicine.symptomDrug Monitoring0305 other medical sciencebusiness030217 neurology & neurosurgerymedicine.drugAlcohol DeterrentsAlcohol and alcoholism (Oxford, Oxfordshire)
researchProduct

Psychiatric symptoms in patients with post-H1N1 narcolepsy type 1 in Norway.

2019

Study objectives Several studies have reported psychiatric comorbidity in patients with narcolepsy type 1 (NC1). The primary aim of this study was to explore the extent of psychiatric symptoms in a cohort of Norwegian NC1 patients, most of whom were H1N1-vaccinated. We also wanted to explore possible causes of the psychiatric symptoms seen in NC1. Methods Cross-sectional study. Psychiatric symptoms were assessed by the Achenbach System of Empirically Based Assessment (ASEBA) Child Behavior Check List (CBCL) in children and by Adult Self Report (ASR) in adults. Results The mean (SD) total T-scores were 58.6 (9.2) for children and 57.0 (9.8) for adults, these being mainly driven by internaliz…

AdultMalemedicine.medical_specialtyAdolescentExcessive daytime sleepinessCBCLNorwegianCohort Studies03 medical and health sciences0302 clinical medicineInfluenza A Virus H1N1 SubtypePhysiology (medical)Surveys and QuestionnairesInfluenza HumanmedicinePandemrixHumansIn patientPsychiatryChildNarcolepsyOrexinsbusiness.industryNorwayMental Disordersmedicine.diseaselanguage.human_languageCross-Sectional Studies030228 respiratory systemInfluenza VaccinesCohortlanguageSleep DeprivationFemaleNeurology (clinical)medicine.symptombusinessCheck List030217 neurology & neurosurgeryNarcolepsySleep
researchProduct

A multi-centre cohort study of short term outcomes of hospital treatment for anorexia nervosa in the UK

2013

Background Individual, family and service level characteristics and outcomes are described for adult and adolescent patients receiving specialist inpatient or day patient treatment for anorexia nervosa (AN). Potential predictors of treatment outcome are explored. Method Admission and discharge data were collected from patients admitted at 14 UK hospital treatment units for AN over a period of three years (adult units N = 12; adolescent N = 2) (patients N = 177). Results One hundred and seventy-seven patients with a severe and enduring illness with wide functional impairment took part in the study. Following inpatient care, physical improvement was moderate/good with a large increase in BMI,…

AdultMalemedicine.medical_specialtyAnorexia NervosaAdolescentSelf-conceptTreatment responseCohort StudiesFeeding and Eating DisordersPatient satisfactionmedicineHumansExpressed emotionPsychiatryInpatientsInpatient carePredictorsbusiness.industrymedicine.diseaseSelf ConceptUnited KingdomTreatmentHospitalizationPsychiatry and Mental healthEating disordersTreatment OutcomeMoodPatient SatisfactionAnorexia nervosa (differential diagnoses)Eating disordersFemalebusinessResearch ArticleCohort studyBMC Psychiatry
researchProduct

Neuropsychological Impairments in Anorexia Nervosa: A Spanish Sample Pilot Study

2014

This work was aimed at obtaining a profile of neuropsychological impairments in young Spanish participants with anorexia nervosa (AN) to demonstrate that right-hemisphere and frontal capacity impairments are present not only in the acute phase but also after weight recovery in a Spanish sample compared with a healthy control group. Twelve patients with AN in the acute phase (body mass index [BMI]= 17) matched by age, IQ, and educational level by utilizing a wide neuropsychological battery. Differences were found between AN groups only for long-term verbal memory, which worsens as BMI increases. Among participants with AN as a group, results showed differences in speed of information process…

AdultMalemedicine.medical_specialtyAnorexia NervosaAdolescenthealth promotionIntelligenceStatistics as TopicPilot ProjectsNeuropsychological TestsAudiologyBody Mass IndexcognitiveYoung AdultVisual memoryDevelopmental and Educational PsychologymedicineHumansAttentionPsychiatryWorking memoryNeuropsychologyAnorèxia nerviosaCognitionNeuropsychological batteryFrontal LobeInhibition PsychologicalMemory Short-TermNeuropsychology and Physiological PsychologyPsicologiaSpainAnorexia nervosa (differential diagnoses)adolescentFemaleVerbal memoryCognition DisordersPsychologyBody mass indexApplied Neuropsychology: Adult
researchProduct